|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Center MM, Jemal A, Smith RA and Ward E:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang WQ, Fu FF, Li YX, Wang WB, Wang HH,
Jiang HP and Teng LS: Molecular biomarkers of colorectal cancer:
Prognostic and predictive tools for clinical practice. J Zhejiang
Univ Sci B. 13:663–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Z, Jiang W, Zhang Z, Qian M and Du B:
Nitidine chloride inhibits LPS-induced inflammatory cytokines
production via MAPK and NF-kappaB pathway in raw 264.7 cells. J
Ethnopharmacol. 144:145–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Del Poeta M, Chen SF, Von Hoff D, Dykstra
CC, Wani MC, Manikumar G, Heitman J, Wall ME and Perfect JR:
Comparison of in vitro activities of camptothecin and nitidine
derivatives against fungal and cancer cells. Antimicrob Agents
Chemother. 43:2862–2868. 1999.PubMed/NCBI
|
|
8
|
Fang Z, Tang Y, Jiao W, Xing Z, Guo Z,
Wang W, Xu Z and Liu Z: Nitidine chloride induces apoptosis and
inhibits tumor cell proliferation via suppressing ERK signaling
pathway in renal cancer. Food Chem Toxicol. 66:210–216. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang Z, Tang Y, Jiao W, Xing Z, Guo Z,
Wang W, Shi B, Xu Z and Liu Z: Nitidine chloride inhibits renal
cancer cell metastasis via suppressing AKT signaling pathway. Food
Chem Toxicol. 60:246–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pan X, Han H, Wang L, Yang L, Li R, Li Z,
Liu J, Zhao Q, Qian M, Liu M and Du B: Nitidine chloride inhibits
breast cancer cells migration and invasion by suppressing c-Src/FAK
associated signaling pathway. Cancer Lett. 313:181–191. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun M, Zhang N, Wang X, Cai C, Cun J, Li
Y, Lv S and Yang Q: Nitidine chloride induces apoptosis, cell cycle
arrest, and synergistic cytotoxicity with doxorubicin in breast
cancer cells. Tumour Biol. 35:10201–10212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liao J, Xu T, Zheng JX, Lin JM, Cai QY, Yu
DB and Peng J: Nitidine chloride inhibits hepatocellular carcinoma
cell growth in vivo through the suppression of the JAK1/STAT3
signaling pathway. Int J Mol Med. 32:79–84. 2013.PubMed/NCBI
|
|
13
|
Chen J, Wang J, Lin L, He L, Wu Y, Zhang
L, Yi Z, Chen Y, Pang X and Liu M: Inhibition of STAT3 signaling
pathway by nitidine chloride suppressed the angiogenesis and growth
of human gastric cancer. Mol Cancer Ther. 11:277–287. 2012.
View Article : Google Scholar
|
|
14
|
Sebolt-Leopold JS and English JM:
Mechanisms of drug inhibition of signalling molecules. Nature.
441:457–462. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai Q, Lin J, Wei L, Zhang L, Wang L, Zhan
Y, Zeng J, Xu W, Shen A, Hong Z and Peng J: Hedyotis diffusa Willd
inhibits colorectal cancer growth in vivo via inhibition of STAT3
signaling pathway. Int J Mol Sci. 13:6117–6128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Surh YJ: Cancer chemoprevention with
dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan AC, Konczak I, Sze DM and Ramzan I:
Molecular pathways for cancer chemoprevention by dietary
phytochemicals. Nutr Cancer. 63:495–505. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thomasset SC, Berry DP, Garcea G, Marczylo
T, Steward WP and Gescher AJ: Dietary polyphenolic
phytochemicals-promising cancer chemopreventive agents in humans? A
review of their clinical properties. Int J Cancer. 120:451–458.
2007. View Article : Google Scholar
|
|
20
|
Zhang Y, Zhuang Z, Meng Q, Jiao Y, Xu J
and Fan S: Polydatin inhibits growth of lung cancer cells by
inducing apoptosis and causing cell cycle arrest. Oncology Lett.
7:295–301. 2014.
|
|
21
|
Reed JC: Bcl-2: Prevention of apoptosis as
a mechanism of drug resistance. Hematol Oncol Clin North Am.
9:451–473. 1995.PubMed/NCBI
|
|
22
|
Brady HJ and Gil-Gómez G: Bax. The
pro-apoptotic Bcl-2 family member, Bax. Int J Biochem Cell Biol.
30:647–650. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baffy G, Miyashita T, Williamson JR and
Reed JC: Apoptosis induced by withdrawal of interleukin-3 (IL-3)
from an IL-3-dependent hematopoietic cell line is associated with
repartitioning of intracellular calcium and is blocked by enforced
Bcl-2 oncoprotein production. J Biol Chem. 268:6511–6519.
1993.PubMed/NCBI
|
|
24
|
Precht TA, Phelps RA, Linseman DA, Butts
BD, Le SS, Laessig TA, Bouchard RJ and Heidenreich KA: The
permeability transition pore triggers Bax translocation to
mitochondria during neuronal apoptosis. Cell Death Differ.
12:255–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Antonsson B: Bax and other pro-apoptotic
Bcl-2 family 'killer-proteins' and their victim the mitochondrion.
Cell Tissue Res. 306:347–361. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Crompton M: Bax, Bid and the
permeabilization of the mitochondrial outer membrane in apoptosis.
Curr Opin Cell Biol. 12:414–419. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu Q: Restoring p53-mediated apoptosis in
cancer cells: New opportunities for cancer therapy. Drug Resist
Updat. 9:19–25. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thompson N and Lyons J: Recent progress in
targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug
discovery. Curr Opin Pharmacol. 5:350–356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gendron S, Couture J and Aoudjit F:
Integrin alpha2beta1 inhibits Fas-mediated apoptosis in T
lymphocytes by protein phosphatase 2A-dependent activation of the
MAPK/ERK pathway. J Biol Chem. 278:48633–48643. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shelton JG, Steelman LS, White ER and
McCubrey JA: Synergy between PI3K/Akt and Raf/MEK/ERK pathways in
IGF-1R mediated cell cycle progression and prevention of apoptosis
in hematopoietic cells. Cell Cycle. 3:372–379. 2004.PubMed/NCBI
|
